HomeAI · summaries
Storia in 15 fonti
FDA approves first cholesterol pill to match powerful injectable drugs
Merck’s once-daily Lipfendra offers a pill alternative to injectable cholesterol drugs after Phase 3 trials involving Israeli patients
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
FDA approves Lipfendra, the first oral PCSK9 inhibitor, to lower LDL
Merck and the FDA announced the approval of enlicitide 20 mg as an add-on to diet and exercise to lower LDL in adults with hypercholesterolemia and those with heterozygous…
- ·
biopharmadive.com
Merck wins first approval of a PCSK9 cholesterol pill
The speedy clearance of Lipfendra is an important milestone for Merck and the result of a controversial voucher program put in place by former commissioner Marty Makary.
- ·
medpagetoday.com
FDA Approves First PCSK9 Inhibitor in Pill Form
With enlicitide, large LDL cholesterol reductions possible without a needle
- ·
cnn.com
Merck’s cholesterol pill gets US FDA approval | CNN
Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s nod, bolstering the drugmaker’s efforts to…
- ·
nbcnews.com
FDA approves new kind of cholesterol pill
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way than a statin to lower cholesterol.
- ·
thestar.com
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been available…
- ·
benzinga.com
FDA Approval Adds New Cholesterol Treatment Option in Merck Portfolio - Merck & Co (NYSE:MRK)
Merck's Lipfendra wins FDA approval as the first oral PCSK9 inhibitor for adults with high LDL cholesterol after positive Phase 3 results.
- ·
economictimes.indiatimes.com
Merck gets US FDA nod for first-in-its-class oral cholesterol drug
The U.S. FDA has approved Merck's new cholesterol-lowering pill, Lipfendra. This oral medication works by blocking the PCSK9 protein, which helps lower bad cholesterol. Lipfendra…
- ·
fortune.com
The cholesterol shot you couldn’t afford is now a pill | Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.
- ·
upi.com
FDA approves first pill to significantly lower 'bad' cholesterol - UPI.com
The Food and Drug Administration on Thursday approved Merck's Lipfendra, which some have hailed as a breakthrough in cholesterol management.
- ·
abcnews.com
FDA approves 1st-of-its-kind pill to reduce cholesterol
The Food and Drug Administration (FDA) approved on Thursday a first-of-its-kind oral option that can lower "bad" LDL cholesterol with a daily pill instead of a shot.
- ·
forbes.com
A Novel Pill For Cholesterol: FDA Approves Lipfendra
The FDA approved Lipfendra (enlicitide), the first oral PCSK9 inhibitor, on July 16, 2026.
- ·
lanacion.com.ar
La FDA aprueba una nueva pastilla para reducir drásticamente los niveles de colesterol
Las nuevas pastillas pueden bajar los niveles de colesterol mucho más de lo que se puede lograr con estatinas, según demostraron los ensayos clínicos
- ·
ynetnews.com
FDA approves first cholesterol pill to match powerful injectable drugs
Merck’s once-daily Lipfendra offers a pill alternative to injectable cholesterol drugs after Phase 3 trials involving Israeli patients
- ·
hindustantimes.com
What do we know about the new cholesterol pill, Lipfendra? Merck's new once-a-day drug gets FDA nod
The FDA has approved Merck's once-daily cholesterol pill Lipfendra (enlicitide), marking the first oral PCSK9 inhibitor.